Literature DB >> 3682439

Gastric cancer with synchronous unresectable hepatic metastasis and a positive response to chemotherapy--report of two cases.

S Fujimoto1, R D Shrestha, J Kasanuki, M Kokubun, N Ichiki, A Miyazaki, M Ohta, K Okui.   

Abstract

We report herein the clinical events seen in two longterm survivors of gastric cancer with unresectable synchronous hepatic metastases. Partial gastrectomy was performed against the primary lesion and continuous intra-arterial infusion of anti-tumor drugs, followed by prolonged systemic antitumor drug treatment, were prescribed. A 43-year-old man with moderately-differentiated tubular adenocarcinoma had an uneventful course during his first 21 postoperative months. However, multiple liver metastases became manifest at 24 months and enlargement of the intrahepatic foci led to death 27 months after gastrectomy. A 51-year-old woman with moderately-differentiated tubular adenocarcinoma had an uneventful postoperative course and is now well with no signs of recurrence 6 years and 6 months after gastrectomy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3682439     DOI: 10.1007/bf02470706

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  8 in total

1.  Factors influencing survival in patients with untreated hepatic metastases.

Authors:  B M Jaffe; W L Donegan; F Watson; J S Spratt
Journal:  Surg Gynecol Obstet       Date:  1968-07

2.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

3.  Major hepatic resections for metastatic colorectal cancer.

Authors:  M A Adson; J A Van Heerden
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

4.  Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer.

Authors:  S Fujimoto; U Kitsukawa; K Itoh
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

5.  Regional chemotherapy of colorectal cancer metastatic to the liver.

Authors:  J E Niederhuber; W Ensminger; J Gyves; J Thrall; S Walker; E Cozzi
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

6.  A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.

Authors:  C M Balch; M M Urist; S J Soong; M McGregor
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

7.  Evaluation of treatment for gastric cancer with liver metastasis.

Authors:  K Okuyama; K Isono; I K Juan; S Onoda; T Ochiai; Y Yamamoto; Y Koide; H Satoh
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

8.  Experience with 150 liver resections.

Authors:  S Iwatsuki; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

  8 in total
  1 in total

1.  Early gastric cancer associated with synchronous liver metastasis and portal tumorous embolism: report of a case.

Authors:  Y Nakata; Y Watanabe; T Nakata; K Kimura; M Sato; K Kawachi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.